Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain.

The European respiratory journal - 1 Mar 2024

Kerem Eitan, Orenti Annalisa, Adamoli Arianna, Hatziagorou Elpis, Naehrlich Lutz, Sermet-Gaudelus Isabelle

Abstract excerpt

BACKGROUND: Prognosis and disease severity in cystic fibrosis (CF) are linked to declining lung function. To characterise lung function by the number of adults in countries with different levels of Gross National Income (GNI), data from the European Cystic Fibrosis Society Patient Registry were utilised. METHODS: Annual data including age, forced expiratory volume in 1 s (FEV1), anthropometry, genotype,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Europe

Share to Longevity

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 38302155
DOI: 10.1183/13993003.01241-2023
PMCID: PMC10918317

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain.PMID 38302155Read ↗

The ageing of people living with cystic fibrosis: what to expect now?Semantic proximity Read ↗

A new era for people with cystic fibrosis.Semantic proximity Read ↗

Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation.Semantic proximity Read ↗

Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation.Semantic proximity Read ↗

Cystic fibrosis year in review 2020: Section 2 pulmonary disease, infections, and inflammation.Semantic proximity Read ↗

Cystic Fibrosis: A Review.Semantic proximity Read ↗

The Changing Epidemiology of Cystic Fibrosis: The Implications for Adult Care.Semantic proximity Read ↗

Disease severity of people with cystic fibrosis carrying residual function mutations: Data from the ECFS Patient Registry.Semantic proximity Read ↗

Cystic fibrosis year in review 2021.Semantic proximity Read ↗

Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy.Semantic proximity Read ↗

Review of Rapid Advances in Cystic Fibrosis.Semantic proximity Read ↗

The impact of progressive expansion of elexacaftor-tezacaftor-ivacaftor availability on lung transplant for cystic fibrosis in France.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.